Vagus nerve inflammation contributes to dysautonomia in COVID-19

Acta Neuropathol. 2023 Sep;146(3):387-394. doi: 10.1007/s00401-023-02612-x. Epub 2023 Jul 15.

Abstract

Dysautonomia has substantially impacted acute COVID-19 severity as well as symptom burden after recovery from COVID-19 (long COVID), yet the underlying causes remain unknown. Here, we hypothesized that vagus nerves are affected in COVID-19 which might contribute to autonomic dysfunction. We performed a histopathological characterization of postmortem vagus nerves from COVID-19 patients and controls, and detected SARS-CoV-2 RNA together with inflammatory cell infiltration composed primarily of monocytes. Furthermore, we performed RNA sequencing which revealed a strong inflammatory response of neurons, endothelial cells, and Schwann cells which correlated with SARS-CoV-2 RNA load. Lastly, we screened a clinical cohort of 323 patients to detect a clinical phenotype of vagus nerve affection and found a decreased respiratory rate in non-survivors of critical COVID-19. Our data suggest that SARS-CoV-2 induces vagus nerve inflammation followed by autonomic dysfunction which contributes to critical disease courses and might contribute to dysautonomia observed in long COVID.

Keywords: COVID-19; Dysautonomia; Neuroinflammation; Vagus nerve.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / complications
  • Endothelial Cells
  • Humans
  • Inflammation
  • Post-Acute COVID-19 Syndrome
  • Primary Dysautonomias* / etiology
  • RNA, Viral
  • SARS-CoV-2
  • Vagus Nerve

Substances

  • RNA, Viral